Randomized trial of adjuvant chemotherapy versus central after curative resection for gastric cancer: 5-year follow-up

被引:50
作者
Neri, B [1 ]
Cini, G
Andreoli, F
Boffi, B
Francesconi, D
Mazzanti, R
Medi, F
Mercatelli, A
Romano, S
Siliani, L
Tarquini, R
Moretti, R
机构
[1] Univ Florence, Dept Internal Med, I-50121 Florence, Italy
[2] Univ Florence, Oncol Day Hosp, I-50121 Florence, Italy
[3] Univ Florence, Dept Gen Pathol & Expt Oncol, I-50121 Florence, Italy
[4] Univ Florence, Inst Gen Surg, I-50121 Florence, Italy
[5] Careggi Hosp, Dept Surg, Florence, Italy
[6] Civ Hosp, Dept Surg, Viareggio, Italy
[7] Univ Florence, Dept Clin Physiopathol, I-50121 Florence, Italy
关键词
adjuvant chemotherapy; epidoxorubicin; 5-fluorouracil; gastric cancer; leucovorin; randomized trial;
D O I
10.1054/bjoc.2000.1472
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Adjuvant chemotherapy of gastric cancer after curative resection is still subject to discussion. In this study 137 patients with gastric adenocarcinoma, all with positive nodes, were randomized after curative resection so that 69 received epidoxorubicin (EPI), leucovorin (LV) and 5-fluorouracil (5-FU) on days 1-3 every 3 weeks for 7 months, whereas the remaining 68 did not, After a follow-up period of 5 years, 21 of the 69 treated patients (30%) and nine controls (13%) were still alive; median survival time was 18 months for the controls and 31 months for the patients treated with adjuvant chemotherapy (P < 0.01). (C) 2001 Cancer Research Campaign.
引用
收藏
页码:878 / 880
页数:3
相关论文
共 14 条
[1]  
ALEXANDER AR, 1997, CANC PRINCIPLES PRAC, P1021
[2]   A RANDOMIZED TRIAL COMPARING ADJUVANT FLUOROURACIL, DOXORUBICIN, AND MITOMYCIN WITH NO TREATMENT IN OPERABLE GASTRIC-CANCER [J].
COOMBES, RC ;
SCHEIN, PS ;
CHILVERS, CED ;
WILS, J ;
BERETTA, G ;
BLISS, JM ;
RUTTEN, A ;
AMADORI, D ;
CORTESFUNES, H ;
VILLARGRIMALT, A ;
MCARDLE, C ;
RAUSCHECKER, HF ;
BOVEN, E ;
VASSILOPOULOS, P ;
WELVAART, K ;
FERREIRA, EP ;
WIIG, J ;
GISSELBRECHT, C ;
ROUGIER, P ;
WOODS, EMA .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (08) :1362-1369
[3]   INTERNATIONAL TRENDS IN CANCER MORTALITY IN FRANCE, WEST-GERMANY, ITALY, JAPAN, ENGLAND AND WALES, AND THE USA [J].
DAVIS, DL ;
HOEL, D ;
FOX, J ;
LOPEZ, A .
LANCET, 1990, 336 (8713) :474-481
[4]   CANCER MORTALITY IN ITALY, 1982 [J].
DECARLI, A ;
LAVECCHIA, C .
TUMORI, 1988, 74 (06) :623-632
[5]  
DOUGLASS HO, 1982, CANCER-AM CANCER SOC, V49, P1116
[6]   Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: Revisiting a meta-analysis of randomised trials [J].
Earle, CC ;
Maroun, JA .
EUROPEAN JOURNAL OF CANCER, 1999, 35 (07) :1059-1064
[7]  
FENOGLIOPREISER CM, 1997, ASCO ED BOOK, P275
[8]  
HERMANEK P, 1987, CLASSIFICATION MALIG
[9]  
Kelsen DP, 1996, SEMIN ONCOL, V23, P379
[10]  
MICHELASSI F, 1994, SURGERY, V116, P804